Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma

CONCLUSION: The anti-gene IGF-I vaccines continue to be applied in current GBM personalized medicine. Technical improvements in the preparation of AS and TH vaccines to increase MHC-1 and B7 immunogenicity have, in parallel, allowed to increase in the median survival of patients.PMID:38031775 | DOI:10.2174/0109298673237968231106095141
Source: Current Medicinal Chemistry - Category: Chemistry Authors: Source Type: research